Jubilant Pharmova Limited (NSE: JUBLPHARMA)
India
· Delayed Price · Currency is INR | Market Cap | 180.71B |
| Revenue (ttm) | 69.20B |
| Net Income (ttm) | 5.93B |
| Shares Out | n/a |
| EPS (ttm) | 37.33 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | Aug 2, 2024 |
| Volume | 76,010 |
| Open | 1,120.10 |
| Previous Close | 1,130.35 |
| Day's Range | 1,120.10 - 1,147.00 |
| 52-Week Range | 409.40 - 1,309.90 |
| Beta | 1.59 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 25, 2024 |
About Jubilant Pharmova
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary ... [Read more]
Financial Performance
Financial StatementsNews
Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer
WOODCLIFF LAKE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTC: EGRX) (the "Company" or "Eagle") today announced the appointment of Christopher Krawtschuk as Chief Financial...
CLSA maintains ‘Underperform’ rating on Jubilant FoodWorks with target price of Rs 445, expecting 26% downside
CLSA has reiterated its ‘Underperform’ rating on Jubilant FoodWorks, setting a target price of ₹445, indicating a potential 26% downside from the current market price (CMP) of ₹602.60. Key insights fr...
Jefferies maintains ‘Buy’ rating on Jubilant FoodWorks with target price of Rs 880, expecting 46% upside
Jefferies has reiterated its ‘Buy’ rating on Jubilant FoodWorks, setting a target price of ₹880, indicating a potential 46% upside from the current market price (CMP) of ₹602.60. Key takeaways from Je...
Morgan Stanley maintains ‘Equal-weight’ rating on Jubilant FoodWorks with target price of Rs 620
Morgan Stanley has reiterated its ‘Equal-weight’ rating on Jubilant FoodWorks, setting a target price of ₹620, indicating a modest upside from the current market price (CMP) of ₹602.60. Key insights f...
Stocks to Watch: RIL, Adani Enterprises, BEL, GAIL, Kaynes Technology, Lupin, Jubilant Pharma, Zomato and morein focus today (Sept 30, 2024)
Indian benchmark indices ended lower on September 27, with the Nifty slipping below 26,200. The BSE Midcap and Smallcap indices remained relatively flat. The top losers on the Nifty included Power Gri...